Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients



Status:Completed
Conditions:Food Studies
Therapuetic Areas:Pharmacology / Toxicology
Healthy:No
Age Range:18 - Any
Updated:5/30/2018
Start Date:December 2016
End Date:March 2018

Use our guide to learn which trials are right for you!

Assessing the Impact of a Comprehensive Nutrition-Focused Quality Improvement Program (QIP) on Health and Economic Outcomes of Malnourished Adult Patients Across the Continuum of Care

A nutrition-focused QIP will be implemented as standard of care at select branches of the
home health division of the health care system. The QIP will be comprised of three groups of
patients, Group 1 will consist of hospitalized, at-risk/malnourished patients being
discharged to home health, Group 2 will consist of outpatients at-risk/malnourished patients
enrolled in home health and Group 3 will consist of SNF, at-risk/malnourished patients being
discharged to home health. Groups will be followed for 90 days post enrollment. The QIP
groups will be compared to historical controls, concurrent controls, and matched concurrent
controls across other sites within the health system.


Inclusion Criteria:

- Admitted to home health from within the healthcare system's hospitals, skilled nursing
facility (SNF) or outpatient clinics

- Patient is screened positive for malnutrition during hospital stay and/or by home
health nutrition screening tool upon enrollment into home health

- Patient is able to consume foods and beverages orally and the physician has not
indicated otherwise

Exclusion Criteria:

- Enrollment to home health from a hospital, SNF or outpatient clinic not affiliated
with the healthcare system

- Patient is pregnant

- Patient is intubated, receiving tube feeding or parenteral nutrition

- Patient has severe dementia or delirium

- History of significant psychiatric disorder

- Any other disorder that may interfere with QIP product consumption or compliance with
QIP protocol procedures as per the admitting clinicians

- Subject has stated an allergy or intolerance to any of the ONS ingredients

- Patients receiving hospice care
We found this trial at
2
sites
1301 Lee Street
Des Plaines, Illinois 60018
Principal Investigator: Krishnan Sriram, MD
?
mi
from
Des Plaines, IL
Click here to add this to my saved trials
10201C South Cicero Avenue
Oak Lawn, Illinois 60453
Principal Investigator: Krishnan Sriram, MD
?
mi
from
Oak Lawn, IL
Click here to add this to my saved trials